23
Feb

After seeing its reputation as a leader in multiple sclerosis erode over recent years, Merck KGaA has decided to carve back the number of staffers working in preclinical R&D in the field.

…read more

Source: UPDATED: Merck KGaA carves into MS R&D after a string of setbacks

    

0 No comments